Tags

Type your tag names separated by a space and hit enter

Effects of acute and chronic desipramine treatment on somatostatin receptors in brain.
Psychopharmacology (Berl). 1992; 108(3):363-6.P

Abstract

The effects of acute (5 mg/kg, IP twice daily for 2 days) and chronic (5 mg/kg IP twice daily for 21 days) administration of desipramine (DMI) on [125I]-Tyr11-somatostatin binding sites in brain were examined. There was no change in [125I]Tyr11-somatostatin binding in membranes prepared from the frontal cortex, striatum, and hippocampus of rats acutely or chronically treated with DMI as compared to non treated animals. [125I]Tyr11-somatostatin binding was increased in membranes prepared from the rat nucleus accumbens only after chronic DMI administration. Scatchard analysis of the binding data from the nucleus accumbens showed that [125I]Tyr11-somatostatin labels a single population of somatostatin binding sites with an affinity constant, Kd, of 1.8 +/- 0.60 nM and a Bmax of 330 +/- 90 fmol/mg protein. Chronic treatment with DMI increased the Bmax (500 +/- 140 fmol/mg protein) but had no effect on the Kd. This finding shows a regional effect of DMI on [125I]Tyr11-somatostatin binding sites in rat brain and suggests that somatostatin may play a role in the pathophysiology of depression.

Authors+Show Affiliations

Department of Basic Sciences, School of Health Sciences, University of Crete, Heraklion, Greece.No affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article
Research Support, Non-U.S. Gov't

Language

eng

PubMed ID

1355925

Citation

Gheorvassaki, E G., et al. "Effects of Acute and Chronic Desipramine Treatment On Somatostatin Receptors in Brain." Psychopharmacology, vol. 108, no. 3, 1992, pp. 363-6.
Gheorvassaki EG, Thermos K, Liapakis G, et al. Effects of acute and chronic desipramine treatment on somatostatin receptors in brain. Psychopharmacology (Berl). 1992;108(3):363-6.
Gheorvassaki, E. G., Thermos, K., Liapakis, G., & Spyraki, C. (1992). Effects of acute and chronic desipramine treatment on somatostatin receptors in brain. Psychopharmacology, 108(3), 363-6.
Gheorvassaki EG, et al. Effects of Acute and Chronic Desipramine Treatment On Somatostatin Receptors in Brain. Psychopharmacology (Berl). 1992;108(3):363-6. PubMed PMID: 1355925.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Effects of acute and chronic desipramine treatment on somatostatin receptors in brain. AU - Gheorvassaki,E G, AU - Thermos,K, AU - Liapakis,G, AU - Spyraki,C, PY - 1992/1/1/pubmed PY - 1992/1/1/medline PY - 1992/1/1/entrez SP - 363 EP - 6 JF - Psychopharmacology JO - Psychopharmacology (Berl) VL - 108 IS - 3 N2 - The effects of acute (5 mg/kg, IP twice daily for 2 days) and chronic (5 mg/kg IP twice daily for 21 days) administration of desipramine (DMI) on [125I]-Tyr11-somatostatin binding sites in brain were examined. There was no change in [125I]Tyr11-somatostatin binding in membranes prepared from the frontal cortex, striatum, and hippocampus of rats acutely or chronically treated with DMI as compared to non treated animals. [125I]Tyr11-somatostatin binding was increased in membranes prepared from the rat nucleus accumbens only after chronic DMI administration. Scatchard analysis of the binding data from the nucleus accumbens showed that [125I]Tyr11-somatostatin labels a single population of somatostatin binding sites with an affinity constant, Kd, of 1.8 +/- 0.60 nM and a Bmax of 330 +/- 90 fmol/mg protein. Chronic treatment with DMI increased the Bmax (500 +/- 140 fmol/mg protein) but had no effect on the Kd. This finding shows a regional effect of DMI on [125I]Tyr11-somatostatin binding sites in rat brain and suggests that somatostatin may play a role in the pathophysiology of depression. SN - 0033-3158 UR - https://www.unboundmedicine.com/medline/citation/1355925/Effects_of_acute_and_chronic_desipramine_treatment_on_somatostatin_receptors_in_brain_ DB - PRIME DP - Unbound Medicine ER -